Skip to main content
. 2018 Oct 11;74(2):349–360. doi: 10.1111/all.13553

Figure 2.

Figure 2

A, Blocking effect of patient serum in allergen‐IgE binding to B cells over time. ANOVA tests for longitudinal assays were applied; ***P ≤ 0.001, ns: not significant. B, Decrease in IgE‐FAB correlates with increased sIgG 4 levels from baseline at 36 (△), 48 (□), and 60 months (●)